108 related articles for article (PubMed ID: 26523991)
21. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
22. Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls.
de Vries MA; Alipour A; Klop B; van de Geijn GJ; Janssen HW; Njo TL; van der Meulen N; Rietveld AP; Liem AH; Westerman EM; de Herder WW; Cabezas MC
Metabolism; 2015 Feb; 64(2):213-7. PubMed ID: 25456098
[TBL] [Abstract][Full Text] [Related]
23. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
24. The postprandial situation as a pro-inflammatory condition.
de Vries MA; Klop B; Eskes SA; van der Loos TL; Klessens-Godfroy FJ; Wiebolt J; Janssen HW; Westerman EM; Castro Cabezas M
Clin Investig Arterioscler; 2014; 26(4):184-92. PubMed ID: 24866730
[TBL] [Abstract][Full Text] [Related]
25. Coronary leukocyte activation in relation to progression of coronary artery disease.
de Vries MA; Alipour A; Birnie E; Westzaan A; van Santen S; van der Zwan E; Liem AH; van der Meulen N; Cabezas MC
Front Med; 2016 Mar; 10(1):85-90. PubMed ID: 26831871
[TBL] [Abstract][Full Text] [Related]
26. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome.
Vine DF; Takechi R; Russell JC; Proctor SD
Atherosclerosis; 2007 Feb; 190(2):282-90. PubMed ID: 16624317
[TBL] [Abstract][Full Text] [Related]
27. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin.
Halkes CJ; van Dijk H; de Jaegere PP; Plokker HW; van Der Helm Y; Erkelens DW; Castro Cabezas M
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1526-30. PubMed ID: 11557683
[TBL] [Abstract][Full Text] [Related]
28. Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
Tremblay AJ; Lamarche B; Ruel I; Hogue JC; Bergeron J; Gagné C; Couture P
Atherosclerosis; 2004 Feb; 172(2):367-73. PubMed ID: 15019548
[TBL] [Abstract][Full Text] [Related]
29. Postprandial lipemia associates with liver fat content.
Matikainen N; Mänttäri S; Westerbacka J; Vehkavaara S; Lundbom N; Yki-Järvinen H; Taskinen MR
J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790
[TBL] [Abstract][Full Text] [Related]
30. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
[TBL] [Abstract][Full Text] [Related]
31. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function.
Cortés B; Núñez I; Cofán M; Gilabert R; Pérez-Heras A; Casals E; Deulofeu R; Ros E
J Am Coll Cardiol; 2006 Oct; 48(8):1666-71. PubMed ID: 17045905
[TBL] [Abstract][Full Text] [Related]
32. A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease.
Mager DR; Mazurak V; Rodriguez-Dimitrescu C; Vine D; Jetha M; Ball G; Yap J
JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):517-28. PubMed ID: 23223552
[TBL] [Abstract][Full Text] [Related]
33. Fasting serum concentration of apolipoprotein B48 represents residual risks in patients with new-onset and chronic coronary artery disease.
Mori K; Ishida T; Yasuda T; Monguchi T; Sasaki M; Kondo K; Hasokawa M; Nakajima H; Haraguchi Y; Sun L; Shinohara M; Toh R; Nishimura K; Hirata K
Clin Chim Acta; 2013 Jun; 421():51-6. PubMed ID: 23428589
[TBL] [Abstract][Full Text] [Related]
34. Test meals rich in marine long-chain n-3 polyunsaturated fatty acids increase postprandial chylomicron response.
Griffo E; Di Marino L; Patti L; Bozzetto L; Annuzzi G; Cipriano P; Mangione A; Della Pepa G; Cocozza S; Riccardi G; Rivellese AA
Nutr Res; 2014 Aug; 34(8):661-6. PubMed ID: 25193793
[TBL] [Abstract][Full Text] [Related]
35. Markers of intestinally-derived lipoproteins: application to studies of altered diet and meal fatty acid compositions.
Lovegrove JA; Jackson KG; Murphy MC; Brooks CN; Zampelas A; Knapper JM; Wright JW; Gould BJ; Williams CM
Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):9-18. PubMed ID: 10726104
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease.
Yamamoto E; Sugiyama S; Hirata Y; Tokitsu T; Tabata N; Fujisue K; Sugamura K; Sakamoto K; Tsujita K; Matsumura T; Kaikita K; Hokimoto S
Atherosclerosis; 2016 Dec; 255():210-216. PubMed ID: 27612676
[TBL] [Abstract][Full Text] [Related]
37. Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state.
Irawati D; Mamo JC; Soares MJ; Slivkoff-Clark KM; James AP
Atherosclerosis; 2015 Nov; 243(1):236-41. PubMed ID: 26407667
[TBL] [Abstract][Full Text] [Related]
38. Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation.
Schirmer SH; Werner CM; Binder SB; Faas ME; Custodis F; Böhm M; Laufs U
Atherosclerosis; 2012 Nov; 225(1):166-72. PubMed ID: 23017356
[TBL] [Abstract][Full Text] [Related]
39. ApoB-lipoprotein remnant dyslipidemia and high-fat meal intolerance is associated with markers of cardiometabolic risk in youth with obesity.
Krysa JA; Ball GDC; Vine DF; Jetha M; Proctor SD
Pediatr Obes; 2021 May; 16(5):e12745. PubMed ID: 33150705
[TBL] [Abstract][Full Text] [Related]
40. MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin.
Klop B; Verseyden C; Ribalta J; Salazar J; Masana L; Cabezas MC
Clin Investig Arterioscler; 2014; 26(2):49-57. PubMed ID: 24378322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
